JP2004522741A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004522741A5 JP2004522741A5 JP2002559011A JP2002559011A JP2004522741A5 JP 2004522741 A5 JP2004522741 A5 JP 2004522741A5 JP 2002559011 A JP2002559011 A JP 2002559011A JP 2002559011 A JP2002559011 A JP 2002559011A JP 2004522741 A5 JP2004522741 A5 JP 2004522741A5
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- film
- formulation
- composition
- pharmacologically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0100200A SE0100200D0 (sv) | 2001-01-24 | 2001-01-24 | New film coating |
| PCT/SE2002/000103 WO2002058677A1 (en) | 2001-01-24 | 2002-01-22 | New film coating |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004522741A JP2004522741A (ja) | 2004-07-29 |
| JP2004522741A5 true JP2004522741A5 (https=) | 2005-12-22 |
| JP4303471B2 JP4303471B2 (ja) | 2009-07-29 |
Family
ID=20282714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002559011A Expired - Fee Related JP4303471B2 (ja) | 2001-01-24 | 2002-01-22 | 新規フィルム・コーティング |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7959947B2 (https=) |
| EP (1) | EP1355635B1 (https=) |
| JP (1) | JP4303471B2 (https=) |
| KR (1) | KR100874582B1 (https=) |
| CN (1) | CN1218692C (https=) |
| AT (1) | ATE285229T1 (https=) |
| AU (1) | AU2002225573B2 (https=) |
| BR (1) | BR0206515A (https=) |
| CA (1) | CA2433530A1 (https=) |
| DE (2) | DE60202351T2 (https=) |
| DK (1) | DK1355635T3 (https=) |
| ES (1) | ES2233804T3 (https=) |
| IL (2) | IL156623A0 (https=) |
| MX (1) | MXPA03006419A (https=) |
| NO (1) | NO20033305D0 (https=) |
| NZ (1) | NZ526792A (https=) |
| PT (1) | PT1355635E (https=) |
| SE (1) | SE0100200D0 (https=) |
| SI (1) | SI1355635T1 (https=) |
| WO (1) | WO2002058677A1 (https=) |
| ZA (1) | ZA200305457B (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0100200D0 (sv) | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
| EP1355633B1 (en) * | 2001-12-19 | 2005-01-19 | AstraZeneca AB | NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate |
| US8323692B2 (en) | 2002-02-21 | 2012-12-04 | Valeant International Bermuda | Controlled release dosage forms |
| CA2476201C (en) * | 2002-02-21 | 2009-09-01 | Biovail Laboratories Incorporated | Modified release formulations of at least one form of tramadol |
| SE0201110D0 (sv) * | 2002-04-12 | 2002-04-12 | Astrazeneca Ab | New film coating |
| SE0202353D0 (sv) * | 2002-08-01 | 2002-08-01 | Astrazeneca Ab | New film coating |
| WO2004069234A1 (en) * | 2003-02-05 | 2004-08-19 | Ipca Laboratories Limited | Pharmaceutical compositions and process of production thereof |
| NZ547284A (en) * | 2003-10-31 | 2009-12-24 | Hexal Ag | Pharmaceutical agent-containing formulation comprising a coating of a film forming polymer |
| GB0403098D0 (en) | 2004-02-12 | 2004-03-17 | Euro Celtique Sa | Extrusion |
| TWI350762B (en) | 2004-02-12 | 2011-10-21 | Euro Celtique Sa | Particulates |
| LT2801354T (lt) | 2004-10-08 | 2017-06-26 | Forward Pharma A/S | Kontroliuojamo atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį |
| JP2012514623A (ja) * | 2009-01-09 | 2012-06-28 | フォーワード・ファルマ・アクティーゼルスカブ | １またはそれ以上のフマル酸エステルを含む医薬組成物 |
| WO2010079222A1 (en) | 2009-01-09 | 2010-07-15 | Forward Pharma A/S | Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
| US20100303920A1 (en) * | 2009-05-27 | 2010-12-02 | Johan Hjartstam | Aqueous Film Coating Composition / 841 |
| US20110229564A1 (en) * | 2010-03-22 | 2011-09-22 | Amneal Pharmaceuticals, L.L.C. | Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof |
| CA2870134C (en) | 2012-05-02 | 2020-04-28 | Capsugel France SAS | Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas) |
| BR112015018895A2 (pt) | 2013-02-13 | 2017-07-18 | Evonik Roehm Gmbh | composição farmacêutica multiparticulada compreendendo uma multiplicidade de dois tipos de pelotas |
| US20160256399A1 (en) | 2013-11-04 | 2016-09-08 | Capsugel Belgium Nv | Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole |
| CN105085778B (zh) * | 2014-04-22 | 2018-11-16 | 广东华润涂料有限公司 | 用于缓释功能成分的涂料组合物用水性胶乳、其制备方法以及应用 |
| PE20180187A1 (es) | 2015-03-03 | 2018-01-23 | Saniona As | Formulacion de combinacion de tesofensina y betabloqueante |
| SG11201811579VA (en) * | 2016-06-30 | 2019-01-30 | Beckman Coulter Inc | Chemiluminescent substrates |
| ES3040411T3 (en) | 2018-03-22 | 2025-10-30 | Incarda Therapeutics Inc | A novel method to slow ventricular rate |
| WO2026046944A1 (en) * | 2024-08-27 | 2026-03-05 | Basf Se | Coating composition and coated tablet |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB878234A (en) | 1958-12-18 | 1961-09-27 | Roehm & Haas Gmbh | Pharmaceutical coating compositions |
| DE1228757B (de) | 1962-06-28 | 1966-11-17 | Haessle Ab | Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen |
| US3341338A (en) | 1965-05-28 | 1967-09-12 | Union Carbide Corp | Polysiloxane polish formulations |
| DE2031871C3 (de) | 1970-06-27 | 1974-06-27 | Roehm Gmbh, 6100 Darmstadt | Überzugsmasse für Arzneiformen |
| US4330338A (en) | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
| US4353887A (en) * | 1979-08-16 | 1982-10-12 | Ciba-Geigy Corporation | Divisible tablet having controlled and delayed release of the active substance |
| US4916171A (en) | 1984-07-25 | 1990-04-10 | Rohm And Haas Company | Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof |
| SE8404467D0 (sv) | 1984-09-06 | 1984-09-06 | Ferrosan Ab | Controlled-release medical preparations |
| CH666405A5 (de) | 1985-06-24 | 1988-07-29 | Ciba Geigy Ag | Feste, haltbare darreichungsformen mit elastischem filmueberzug. |
| SE450087B (sv) | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
| US5246714A (en) | 1985-10-11 | 1993-09-21 | Aktiebolaget Hassle | Drug preparation |
| SE455836B (sv) | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
| US4975283A (en) | 1985-12-12 | 1990-12-04 | Bristol-Myers Squibb Company | Stabilized enteric coated aspirin granules and process for preparation |
| US4800087A (en) | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
| US4871546A (en) | 1987-06-29 | 1989-10-03 | Sandoz Pharm. Corp. | Gastrointestinal protective coating formulations |
| JP2782691B2 (ja) | 1987-09-29 | 1998-08-06 | ワーナー−ランバート・コンパニー | 腸溶製剤の安定化 |
| FR2655266B1 (fr) | 1989-12-05 | 1992-04-03 | Smith Kline French Lab | Compositions pharmaceutiques a base de cimetidine. |
| JP2558396B2 (ja) | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
| GB9200607D0 (en) | 1992-01-13 | 1992-03-11 | Ethical Pharma Ltd | Pharmaceutical compositions containing nifedipine and process for the preparation thereof |
| US5656296A (en) * | 1992-04-29 | 1997-08-12 | Warner-Lambert Company | Dual control sustained release drug delivery systems and methods for preparing same |
| US5376384A (en) * | 1992-12-23 | 1994-12-27 | Kinaform Technology, Inc. | Delayed, sustained-release pharmaceutical preparation |
| ATE195252T1 (de) * | 1993-04-23 | 2000-08-15 | Novartis Erfind Verwalt Gmbh | Wirkstoffabgabevorrichtung mit gesteuerter freigabe |
| US5484597A (en) * | 1993-07-30 | 1996-01-16 | Chesebrough-Pond's Usa Co. | Clear hydroalcholic cosmetic microemulsions |
| FR2725623A1 (fr) | 1994-10-18 | 1996-04-19 | Flamel Tech Sa | Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os |
| DE4444051A1 (de) | 1994-12-10 | 1996-06-13 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
| US5948438A (en) * | 1995-01-09 | 1999-09-07 | Edward Mendell Co., Inc. | Pharmaceutical formulations having improved disintegration and/or absorptivity |
| US5871776A (en) | 1995-01-31 | 1999-02-16 | Mehta; Atul M. | Controlled-release nifedipine |
| DE69713948D1 (de) * | 1996-04-23 | 2002-08-22 | Janssen Pharmaceutica Nv | Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid |
| US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| US6627223B2 (en) | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
| SE0100200D0 (sv) | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
| EP1355633B1 (en) | 2001-12-19 | 2005-01-19 | AstraZeneca AB | NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate |
| SE0201110D0 (sv) | 2002-04-12 | 2002-04-12 | Astrazeneca Ab | New film coating |
| SE0202353D0 (sv) * | 2002-08-01 | 2002-08-01 | Astrazeneca Ab | New film coating |
-
2001
- 2001-01-24 SE SE0100200A patent/SE0100200D0/xx unknown
-
2002
- 2002-01-22 ES ES02715942T patent/ES2233804T3/es not_active Expired - Lifetime
- 2002-01-22 CN CNB028040813A patent/CN1218692C/zh not_active Expired - Fee Related
- 2002-01-22 KR KR1020037009573A patent/KR100874582B1/ko not_active Expired - Fee Related
- 2002-01-22 BR BR0206515-0A patent/BR0206515A/pt not_active IP Right Cessation
- 2002-01-22 IL IL15662302A patent/IL156623A0/xx active IP Right Grant
- 2002-01-22 US US10/466,099 patent/US7959947B2/en not_active Expired - Fee Related
- 2002-01-22 AT AT02715942T patent/ATE285229T1/de active
- 2002-01-22 DE DE60202351T patent/DE60202351T2/de not_active Expired - Lifetime
- 2002-01-22 JP JP2002559011A patent/JP4303471B2/ja not_active Expired - Fee Related
- 2002-01-22 CA CA002433530A patent/CA2433530A1/en not_active Abandoned
- 2002-01-22 EP EP02715942A patent/EP1355635B1/en not_active Expired - Lifetime
- 2002-01-22 DE DE20220901U patent/DE20220901U1/de not_active Expired - Lifetime
- 2002-01-22 SI SI200230081T patent/SI1355635T1/xx unknown
- 2002-01-22 WO PCT/SE2002/000103 patent/WO2002058677A1/en not_active Ceased
- 2002-01-22 PT PT02715942T patent/PT1355635E/pt unknown
- 2002-01-22 DK DK02715942T patent/DK1355635T3/da active
- 2002-01-22 NZ NZ526792A patent/NZ526792A/xx unknown
- 2002-01-22 MX MXPA03006419A patent/MXPA03006419A/es active IP Right Grant
- 2002-01-22 AU AU2002225573A patent/AU2002225573B2/en not_active Ceased
-
2003
- 2003-06-24 IL IL156623A patent/IL156623A/en not_active IP Right Cessation
- 2003-07-15 ZA ZA200305457A patent/ZA200305457B/en unknown
- 2003-07-22 NO NO20033305A patent/NO20033305D0/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004522741A5 (https=) | ||
| KR100220163B1 (ko) | 지속방출성 코팅체를 갖는 불용성 약물의 즉방성 정제코어를 포함하는 경구투여용 지속방출성 정제 | |
| CN103517708B (zh) | 药物组合物 | |
| JP2009545560A5 (https=) | ||
| CA2651716A1 (en) | Duloxetine hydrochloride delayed release formulations | |
| JP2009530298A5 (https=) | ||
| JP2005514386A5 (https=) | ||
| RU2003125371A (ru) | Новое пленочное покрытие | |
| JP2005526043A5 (https=) | ||
| RU2372893C2 (ru) | Содержащий фармацевтический агент состав с покрытием | |
| JPH05201856A (ja) | アクリルポリマーコーティングを有する高安定性放出制御型薬剤及びその製法 | |
| JP2006514988A5 (https=) | ||
| JPH0710773B2 (ja) | 一定の放出性及び即時放出性を有する薬物粒子 | |
| US12156941B2 (en) | Centanafadine pharmaceutical formulations, and methods of making and using same | |
| CN1674873A (zh) | 药物组合物 | |
| CN110123782A (zh) | 含有药物的中空颗粒 | |
| CN109310642A (zh) | 美沙拉嗪的口服药物组合物 | |
| AU2004315136B2 (en) | Extended release coated microtablets of venlafaxine hydrochloride | |
| CA2697437A1 (en) | Pharmaceutical combination of aliskiren and valsartan | |
| KR20060132891A (ko) | 다중미립자 ｏ－데스메틸벤라팍신 염 및 그의 용도 | |
| US6238703B1 (en) | Controlled release oral dosage form of ketoprofen | |
| JP2005538117A5 (https=) | ||
| US9333175B2 (en) | Controlled release levetiracetam formulations and methods for producing the same | |
| US20160015646A1 (en) | Oral delivery system for sorafenib tosylate | |
| ES2377473B1 (es) | Pellets entéricos de duloxetina. |